Literature DB >> 17999965

Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of Streptococcus pneumoniae from 12 children treated with levofloxacin.

Todd A Davies1, Eugene Leibovitz, Gary J Noel, David F McNeeley, Karen Bush, Ron Dagan.   

Abstract

Children who had acute otitis media and were treated with levofloxacin were assessed for the emergence of fluoroquinolone-resistant Streptococcus pneumoniae. Nasopharynx cultures were obtained from patients at the entry to and during levofloxacin therapy. All nasopharynx isolates (n = 59) from 12 children were levofloxacin susceptible without parC/E or gyrA/B mutations. Pneumococcal nasopharynx persistence was not associated with levofloxacin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999965      PMCID: PMC2223889          DOI: 10.1128/AAC.01068-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Antibiotic treatment in acute Otitis Media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment.

Authors:  R Dagan; E Leibovitz; G Cheletz; A Leiberman; N Porat
Journal:  J Infect Dis       Date:  2001-02-09       Impact factor: 5.226

2.  Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children.

Authors:  R Cohen; E Bingen; E Varon; F de La Rocque; N Brahimi; C Levy; M Boucherat; J Langue; P Geslin
Journal:  Pediatr Infect Dis J       Date:  1997-06       Impact factor: 2.129

3.  Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

Authors:  X S Pan; J Ambler; S Mehtar; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.

Authors:  F Ghaffar; L S Muniz; K Katz; J Reynolds; J L Smith; P Davis; I R Friedland; G H McCracken
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

5.  An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.

Authors:  Adriano Arguedas; Ron Dagan; Michael Pichichero; Eugene Leibovitz; Jeffery Blumer; David F McNeeley; Rama Melkote; Gary J Noel
Journal:  Pediatr Infect Dis J       Date:  2006-12       Impact factor: 2.129

6.  Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).

Authors:  Todd A Davies; Raul Goldschmidt; Sharon Pfleger; Mike Loeloff; Karen Bush; Daniel F Sahm; Alan Evangelista
Journal:  J Antimicrob Chemother       Date:  2003-07-01       Impact factor: 5.790

Review 7.  Otitis media.

Authors:  J O Klein
Journal:  Clin Infect Dis       Date:  1994-11       Impact factor: 9.079

8.  Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome.

Authors:  R Dagan; E Leibovitz; D Greenberg; P Yagupsky; D M Fliss; A Leiberman
Journal:  Pediatr Infect Dis J       Date:  1998-09       Impact factor: 2.129

9.  Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.

Authors:  Eugene Leibovitz; Lolita Piglansky; Simon Raiz; David Greenberg; Kamal A Hamed; Jean-Marie Ledeine; Joseph Press; Alberto Leiberman; Roger M Echols; Phillip F Pierce; Michael R Jacobs; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2003-11       Impact factor: 2.129

10.  Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure.

Authors:  Adriano Arguedas; Larry Sher; Eduardo Lopez; Xavier Sáez-Llorens; Kamal Hamed; Karen Skuba; Phillip F Pierce
Journal:  Pediatr Infect Dis J       Date:  2003-11       Impact factor: 2.129

View more
  1 in total

Review 1.  Safety Concerns Surrounding Quinolone Use in Children.

Authors:  Karisma Patel; Jennifer L Goldman
Journal:  J Clin Pharmacol       Date:  2016-03-28       Impact factor: 3.126

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.